Exelixis
EXEL
#1635
Rank
โ‚ฌ11.39 B
Marketcap
45,35ย โ‚ฌ
Share price
0.06%
Change (1 day)
23.02%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company